XTX Ventures
VC Fund
London, United Kingdom
XTX Ventures is a VC fund in London focused on Artificial Intelligence and Software. XTX Ventures is the venture capital arm of XTX Markets. XTX Markets is a leading, innovation-driven algorithmic trading firm.XTX Ventures focuses on early stage startups (Seed to Series A) applying machine learning and leverages XTX Markets’ deep expertise in ML and financial technology to help grow and enhance those businesses. We are geographyand industry agnostic.
- Total investments:
- 96
- Last investment:
- Lead investor:
- 21%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries XTX Ventures invests in
Stages XTX Ventures invests in
Countries XTX Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $2M–$7.6M
- Series A
- $6M–$60M
Investment Focus
Industry
- Artificial Intelligence 26 (27%)
- Software 19 (20%)
- Machine Learning 16 (17%)
- Health Care 11 (11%)
- Information Technology 7 (7%)
Stage
- Series A 22 (23%)
- Seed 18 (19%)
- Funding Round 7 (7%)
- Series B 6 (6%)
- Pre-Seed 5 (5%)
Country
- United Kingdom 22 (23%)
- United States 19 (20%)
- Israel 3 (3%)
- Spain 1 (1%)
- France 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Gabriele Papievyte
Head of Ventures
|
Head of Ventures | Total investments: 4 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Qureight
|
Qureight is an imaging analytics company. It also aims to develop a new improved and streamlined version of its analytical platform – harnessing the ability of AI and advanced processing tools to gain new insights into respiratory diseases such as Idiopathic Pulmonary Fibrosis (IPF) and lung cancer. | $20M / Series B / Jul 29, 2026 | |
Proxima Fusion
|
Proxima Fusion is a fusion energy company developing stellarator-based fusion power plants to deliver safe, carbon-free, and commercially viable electricity. The company focuses on commercializing quasi-isodynamic (QI) stellarators, a type of magnetic confinement fusion reactor designed to provide continuous and stable plasma operation. ProximaFusion collaborates closely with research institutions, industrial partners, and energy companies across Europe through the Alpha Alliance, a consortium established to scale the manufacturing and engineering capabilities needed for commercial fusion. The company leverages scientific breakthroughs from the Wendelstein 7-X (W7-X) stellarator while developing proprietary engineering, simulation, and manufacturing technologies to industrialize fusion power generation. | $470.1M / Series B / Jul 07, 2026 | |
kopa.ai
|
Kopa is the AI co-pilot for e-commerce brands — built on 9-figure operator expertise.We help digital stores grow faster with less effort by proactively analyzing every corner of the business — from marketing and inventory to pricing, reputation, and customer experience — then deploying AI agents to take action.We believe the future ofe-commerce isn’t just data-driven — it’s autonomous. And we’re building the invisible infrastructure to power it. | $2.3M / Seed / May 28, 2026 | |
Ethos
|
Ethos is an AI-driven platform that matches individuals with opportunities. It uses AI to scan hundreds of millions of profiles and match clients with the most relevant experts for insight-driven calls. The platform streamlines the entire process from booking to communication and compensation, making it equitable for clients and experts. Whilecurrently focused on expert calls, Ethos is expanding to match advisors with startups, speakers with events, and talent with employers. | $22.8M / Series A / May 06, 2026 | |
QMatter
|
QMatter develops simulation tools for molecular modelling based on quantum compression mechanism. | $1.2M / Pre-Seed / Apr 09, 2026 | |
Lucida Medical
|
Software to support analysis of MRI for cancer diagnosis, screening and management. Pi(tm), the company's first product, supports diagnosis of prostate cancer using multiparametric or diffusion MRI and is a CE marked medical device. We are interested to speak with investors and hospital partners who share our vision to find cancer early. | $11.5M / Series A / Mar 30, 2026 | |
Turbine
|
Turbine builds a platform to understand the inner mechanisms of cancer, enabling the discovery of novel protein targets, precision biomarkers, and better translation to patients. Turbine uses its proprietary Simulated Cell technology in combination with Artificial Intelligence to build a faster and deeper biological understanding of therapeutictargets or indications, untangling the complexity of cancer. | $25M / Series B / Feb 24, 2026 | |
Standard Nuclear
|
Standard Nuclear is focused on advancing nuclear energy by providing innovative nuclear fuels to support the next generation of reactors. The company contributes to renewable energy by developing innovative nuclear fuels that enhance efficiency and sustainability, thereby reducing the environmental impact of energy production. By promoting nuclearenergy, the company supports the clean energy transition, providing a stable and reliable power source that complements intermittent renewables like solar and wind. | $140M / Series A / Jan 26, 2026 | |
SOLVE
|
SOLVE have developed novel transient flow techniques that extend the capabilities of current approaches. SOLVE’s products leverage technology for the efficient collection of data from chemical reactions, as well as predictive computational models tuned based on the collected data. Both the data by itself, as well as the models, are used to informthe reaction conditions and solvent mixtures applied to manufacture chemical compounds at different scales of production. | $5.4M / Seed / Jan 16, 2026 | |
Corma
|
Corma streamlines application access, automates the review process, and effectively reduces software expenses. | $4.1M / Seed / Dec 08, 2025 | |
| See all 96 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does XTX Ventures invest in?
XTX Ventures invests primarily in Artificial Intelligence, Software and Machine Learning startups, most often at Series A and Seed stage. Most of the 96 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is XTX Ventures's check size?
XTX Ventures typically joins rounds of $2M–$7.6M at Seed and $6M–$60M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds XTX Ventures participates in.
How do I contact XTX Ventures?
Public channels for XTX Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at XTX Ventures?
The team at XTX Ventures includes Gabriele Papievyte (Head of Ventures). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
